Practice Guideline
doi: 10.1016/j.jacc.2016.03.513.
Epub 2016 Mar 29.
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
- PMID: 27036918
- DOI: 10.1016/j.jacc.2016.03.513
Item in Clipboard
Practice Guideline
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
J Am Coll Cardiol.
.
Free article
No abstract available
Keywords: ACC/AHA Clinical Practice Guideline; P2Y(12) inhibitor; acute coronary syndrome; aspirin; coronary artery disease; coronary stents; dual antiplatelet therapy (DAPT); focused update; stable ischemic heart disease.
Comment in
-
Duration of dual antiplatelet therapy (DAPT): a call for personalized medicine.J Thorac Dis. 2016 Oct;8(10):E1226-E1229. doi: 10.21037/jtd.2016.10.05. J Thorac Dis. 2016. PMID: 27867593 Free PMC article. No abstract available.
Similar articles
-
Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.Circulation. 2016 Sep 6;134(10):e156-78. doi: 10.1161/CIR.0000000000000405. Epub 2016 Mar 29. Circulation. 2016. PMID: 27026019 Review.
-
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.J Thorac Cardiovasc Surg. 2016 Nov;152(5):1243-1275. doi: 10.1016/j.jtcvs.2016.07.044. J Thorac Cardiovasc Surg. 2016. PMID: 27751237 No abstract available.
-
2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery.Circulation. 2016 Sep 6;134(10):e123-55. doi: 10.1161/CIR.0000000000000404. Epub 2016 Mar 29. Circulation. 2016. PMID: 27026020 Review. No abstract available.
-
Perioperative management of dual anti-platelet therapy.Hosp Pract (1995). 2016 Dec;44(5):237-241. doi: 10.1080/21548331.2016.1260997. Epub 2016 Dec 4. Hosp Pract (1995). 2016. PMID: 27846735
-
Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.J Cardiovasc Pharmacol Ther. 2017 Jul;22(4):347-355. doi: 10.1177/1074248416683048. Epub 2016 Dec 21. J Cardiovasc Pharmacol Ther. 2017. PMID: 28587584 Review.
Cited by
-
Application of Peplau's interpersonal relationship theory combined with case management in rehabilitation of patients after primary percutaneous coronary intervention.Front Cardiovasc Med. 2024 Oct 24;11:1420974. doi: 10.3389/fcvm.2024.1420974. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39512374 Free PMC article.
-
Temporal modulation (early escalation and late de-escalation) of antiplatelet therapy in patients undergoing complex high-risk PCI: rationale and design of the TAILORED-CHIP trial.EuroIntervention. 2024 Nov 4;20(21):e1355-e1362. doi: 10.4244/EIJ-D-24-00437. EuroIntervention. 2024. PMID: 39492701 Clinical Trial.
-
A statistical model to identify hereditary and epigenetic fusion genes associated with dilated cardiomyopathy.Front Genet. 2024 Oct 1;15:1438887. doi: 10.3389/fgene.2024.1438887. eCollection 2024. Front Genet. 2024. PMID: 39411373 Free PMC article.
-
Clinical safety and performance of the world's thinnest-strut Evermine50 everolimus-eluting stent: a 24-month follow-up of the Evermine 50 EES - 1 study.AsiaIntervention. 2024 Sep 27;10(3):195-202. doi: 10.4244/AIJ-D-24-00009. eCollection 2024 Sep. AsiaIntervention. 2024. PMID: 39347116 Free PMC article.
-
Real-world evidence of BioMime sirolimus-eluting stent in obstructive coronary artery disease: the meriT-2 trial.AsiaIntervention. 2024 Sep 27;10(3):186-194. doi: 10.4244/AIJ-D-24-00007. eCollection 2024 Sep. AsiaIntervention. 2024. PMID: 39347114 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
